Your browser doesn't support javascript.
loading
Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
Dabbous, Hany M; El-Sayed, Manal H; El Assal, Gihan; Elghazaly, Hesham; Ebeid, Fatma F S; Sherief, Ahmed F; Elgaafary, Maha; Fawzy, Ehab; Hassany, Sahar M; Riad, Ahmed R; TagelDin, Mohamed A.
Affiliation
  • Dabbous HM; Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Ramsis Street, Abbassia Square, Cairo, 11591, Egypt. drhdabbous@gmail.com.
  • El-Sayed MH; Faculty of Medicine, Ain Shams University Research Institute-Clinical Research Centre (MASRI-CRC), Cairo, Egypt.
  • El Assal G; Chest Department, Ain Shams University, Cairo, Egypt.
  • Elghazaly H; Faculty of Medicine, Ain Shams University Research Institute-Clinical Research Centre (MASRI-CRC), Cairo, Egypt.
  • Ebeid FFS; Faculty of Medicine, Ain Shams University Research Institute-Clinical Research Centre (MASRI-CRC), Cairo, Egypt.
  • Sherief AF; Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Ramsis Street, Abbassia Square, Cairo, 11591, Egypt.
  • Elgaafary M; Community Medicine Department, Ain Shams University, Cairo, Egypt.
  • Fawzy E; Tropical Medicine Department, Assiut University, Assiut, Egypt.
  • Hassany SM; Tropical Medicine Department, Assiut University, Assiut, Egypt.
  • Riad AR; Tropical Medicine Department, Assiut University, Assiut, Egypt.
  • TagelDin MA; Chest Department, Ain Shams University, Cairo, Egypt.
Sci Rep ; 11(1): 18983, 2021 09 18.
Article in En | MEDLINE | ID: mdl-34537808

Full text: 1 Database: MEDLINE Type of study: Clinical_trials Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Type of study: Clinical_trials Language: En Year: 2021 Type: Article